Balchem (BCPC)
(Real Time Quote from BATS)
$139.40 USD
+0.14 (0.10%)
Updated Apr 29, 2024 12:21 PM ET
4-Sell of 5 4
F Value B Growth C Momentum D VGM
Income Statements
Fiscal Year end for Balchem Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 922 | 942 | 799 | 704 | 644 |
Cost Of Goods | 620 | 662 | 556 | 480 | 432 |
Gross Profit | 302 | 280 | 243 | 224 | 211 |
Selling & Adminstrative & Depr. & Amort Expenses | 143 | 135 | 116 | 113 | 109 |
Income After Depreciation & Amortization | 159 | 145 | 128 | 111 | 103 |
Non-Operating Income | 1 | -1 | 0 | 0 | 0 |
Interest Expense | 23 | 10 | 2 | 4 | 6 |
Pretax Income | 137 | 134 | 125 | 106 | 96 |
Income Taxes | 29 | 28 | 29 | 22 | 17 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 109 | 105 | 96 | 85 | 80 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 109 | 105 | 96 | 85 | 80 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 214 | 197 | 176 | 162 | 148 |
Depreciation & Amortization (Cash Flow) | 55 | 52 | 49 | 51 | 46 |
Income After Depreciation & Amortization | 159 | 145 | 128 | 111 | 103 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 32.45 | 32.39 | 32.67 | 32.50 | 32.51 |
Diluted EPS Before Non-Recurring Items | 3.35 | 3.25 | 2.94 | 3.32 | 3.19 |
Diluted Net EPS (GAAP) | 3.35 | 3.25 | 2.94 | 2.60 | 2.45 |
Fiscal Year end for Balchem Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 228.70 | 229.95 | 231.25 | 232.54 |
Cost Of Goods | NA | 153.71 | 153.40 | 153.90 | 159.37 |
Gross Profit | NA | 74.99 | 76.54 | 77.35 | 73.17 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 36.66 | 32.93 | 34.52 | 38.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 38.33 | 43.61 | 42.83 | 34.41 |
Non-Operating Income | NA | 0.22 | -0.55 | 0.73 | 0.28 |
Interest Expense | NA | 5.29 | 6.59 | 5.16 | 5.57 |
Pretax Income | NA | 33.27 | 36.48 | 38.40 | 29.12 |
Income Taxes | NA | 6.62 | 7.40 | 8.29 | 6.41 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 26.65 | 29.08 | 30.11 | 22.71 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 26.65 | 29.08 | 30.11 | 22.71 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 32.48 | 32.48 | 32.43 | 32.42 |
Diluted EPS Before Non-Recurring Items | NA | 0.82 | 0.90 | 0.93 | 0.70 |
Diluted Net EPS (GAAP) | NA | 0.82 | 0.90 | 0.93 | 0.70 |